Two projects have received funding from OHSU's 2022 Biomedical Innovation Program, both in the Device, Diagnostic, Software track. The funding program, which is a collaboration between the Oregon...
A rare childhood disease and triple-negative breast cancer are the targets of two projects funded by the drug discovery track of 2022 OCTRI Biomedical Innovation Program awards. The BIP awards...
If you have an idea for a technical innovation to improve health, consider attending this workshop on Sept. 15, noon-1 p.m. You'll walk away understanding the Biomedical Innovation Program awards...
Develop a new way of thinking about research The I-Corps@ NCATS program is a five-week course, based on the National Science Foundation I-Corps and I-Corps at NIH Entrepreneurial Training...
Three drug discovery projects have been named recipients of the 2021 OCTRI’s Biomedical Innovation Program in the program’s drug discovery track. This BIP track supports drug discovery platforms...
OCTRI BIP Device & Diagnostic LOI due: Sept. 23, 2020, 11:59 p.m. PT Application due: Nov. 12, 2020 The OCTRI Biomedical Innovation Program is accepting applications for its Device &...
The OCTRI Biomedical Innovation Program is accepting applications for its Drug Discovery program. The program supports interdisciplinary drug discovery and therapeutic development research at...
Aditi P. Martin, Ph.D., will lead a new office in OHSU Research & Innovation called OHSU Collaborations and Entrepreneurship. Since 2015, Martin has played a leading role in building OHSU...
Xiangshu Xiao, Ph.D., and his team were recently awarded $120,000 to develop a new therapy for drug-resistant ovarian cancer. Ovarian cancer is the deadliest gynecological cancer in the U.S., and...
To support drug discovery and therapeutic technology development efforts at OHSU, a new round of funding from the Biomedical Innovation Program has been announced. The Biomedical Innovation...